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Abstract
Nonlinear mixed-effects models are being widely used for the analysis of longitudinal data,
especially from pharmaceutical research. They use random effects which are latent and unob-
servable variables, so the random-effects distribution is subject to misspecification in practice.
In this paper, we first study the consequences of misspecifying the random-effects distribution in
nonlinear mixed-effects models. Our study is focused on Gauss-Hermite quadrature which is now
the routine method for calculation of the marginal likelihood in mixed models. We then present a
formal diagnostic test to check the appropriateness of the assumed random-effects distribution in
nonlinear mixed-effects models, which is very useful for real data analysis. Our findings show that
the estimates of fixed-effects parameters in nonlinear mixed-effects models are generally robust
to deviations from normality of the random-effects distribution, but the estimates of variance
components are very sensitive to the distributional assumption of random effects. Furthermore,
a misspecified random-effects distribution will either overestimate or underestimate the predic-
tions of random effects. We illustrate the results using a real data application from an intensive
pharmacokinetic study.
Keywords: Diagnostic test; Gauss-Hermite quadrature; Longitudinal data; Nonlinear mixed-
effects models; Prediction; Random-effects distribution.
1. Introduction
Nonlinear mixed-effects models are well suited for the analysis of longitudinal data, especially
from pharmaceutical research. For example, in pharmacokinetics, often a nonlinear function
for drug concentration is achieved over time after administration of a drug and the goal is to
characterise drug disposition1,2. The term “mixed-effects” refers to the presence of both fixed
effects and random effects in the model. Fixed effects are regression parameters constant across
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subjects, while random effects are subject-specific random variables incorporated to capture the
inter-subject variability.
To fit a nonlinear mixed-effects model, one often needs to assume a distribution for the
random effects. Inferences are then based on the marginal likelihood function after integrating
out the random effects over their assumed distribution. It is common to assume that the random
effects follow a (multivariate) normal distribution. However, the normality assumption of random
effects may not always be valid in practice3,4. Since the random-effects distribution is crucial in
the calculation of the marginal likelihood, it is important to study the impact of misspecifying
the random-effects distribution on inferences about parameters and random effects. Note that
it is difficult to find out the true distribution of random effects because they are latent and
unobservable variables.
Unlike linear mixed-effects models that enjoy a closed-form marginal likelihood5, the non-
linear mixed-effects models often produce intractable marginal likelihood functions which need
to be calculated using approximation methods. Davidian and Giltinan 6 classify approximation
methods into two main categories: analytical approximation and numerical approximation. Ana-
lytical approximations are based on analytical manipulations to justify approximations to either
the marginal likelihood or to the first two moments of the individual marginal distributions. Two
commonly used analytical approximations are the first-order expansion (linearisation) and the
Laplace’s approximation. Numerical approximations directly approximate the integrals in the
marginal likelihood by some numerical integration technique. Under the normality assumption
of random effects, a routine numerical approximation is Gauss-Hermite quadrature, although it
can also be used with non-normal random effects7.
It has been shown that numerical approximations generally provide more accurate parame-
ter estimates compared to the analytical approximations. In a recent paper Harring and Liu 8
showed, via extensive simulations, that Gauss-Hermite quadrature outperforms both the first-
order expansion and the Laplace’s approximation in terms of estimation accuracy. Furthermore,
in their simulations with two random effects, they observed that Gauss-Hermite quadrature and
the first-order expansion do not suffer from convergence issues, while the Laplace’s approximation
encounters convergence difficulty.
Unlike linear and generalised linear mixed models9–13, very little is known in the litera-
ture about the impact of a misspecified random-effects distribution on inferences in nonlinear
mixed-effects models. To the best of our knowledge, only two papers have studied the effects of
misspecifying the random-effects distribution in nonlinear mixed-effects models. The first work,
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which has been done by Hartford and Davidian 14 , is based on two analytical approximations of
the marginal likelihood: the first order approximation and the Laplace’s approximation. But,
as discussed above, these two analytical approximations do not generally provide accurate pa-
rameter estimates even if the model is fully correctly specified. Clearly, the actual impact of a
misspecified random-effects distribution will be revealed if a more accurate approximation to the
marginal likelihood is employed. The second work, which is a recent paper by Harring and Liu 8 ,
mainly aimed to compare several different methods for estimation of the parameters, rather than
focus on the impact of misspecifying the random-effects distribution.
After its availability in standard software in the last decade, Gauss-Hermite quadrature has
become the routine method for calculation of the marginal likelihood in mixed models especially
the nonlinear mixed-effects models. As already discussed, Gauss-Hermite quadrature generally
provides reliable parameter estimates. In this paper, we first focus on nonlinear mixed-effects
models and study the consequences of misspecifying the random-effects distribution when Gauss-
Hermite quadrature is used. Our investigation not only targets the estimates of model parameters
but also concerns the prediction of random effects which is a kind of ‘individual inference’. The
impact on individual inference has not been studied in the context of nonlinear mixed-effects
models. We then describe a formal diagnostic test to check the adequacy of the assumed random-
effects distribution in nonlinear mixed-effects models, which is very helpful for practical use.
2. Nonlinear mixed-effects models
In this section, we briefly explain the general form of nonlinear mixed-effects models for the
analysis of longitudinal data. For a detailed discussion, see Fitzmaurice et al. 15 . Consider a
longitudinal study in which N subjects are followed over time. Let Yi1, . . . , Yini be ni repeated
measurements on the ith subject, where Yij is the outcome for subject i measured at time tij .
For example, Yij could be the blood pressure measured after administration of a drug. Also,
let Wi denote a vector of within-subject covariates for subject i. Likewise, let Xi be a vector
of between-subject covariates for subject i that do not change during the study. The nonlinear
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mixed-effects model can then be expressed as a two-stage hierarchy as follows:
Stage 1: Individual-Level Model
Yij = m(tij ,Wi, φi) + εij , j = 1, . . . , ni,
Stage 2: Population Model
φi = h(Xi, β, bi), i = 1, . . . , N.
(1)
In stage 1, m is a nonlinear function of time tij , depending on the within-subject covariates
Wi and an r × 1 vector of parameters φi specific to subject i. Also, εij ’s are independent
measurements errors, each of which has a normal distribution with mean 0 and variance σ2. In
stage 2, h is an r-dimensional function that describes the relationship between the elements of φi
and the between-subject covariates Xi in terms of a p× 1 fixed parameter β whose elements are
referred to as fixed effects, and a q × 1 vector bi of random effects representing the inter-subject
variability. Because φi can vary from subject to subject, the random effects bi are incorporated
to capture the inter-subject variability through a hierarchical analysis. The random effects bi,
which are unobservable variables with an unknown distribution, are typically assumed to have
a multivariate normal distribution with mean 0 and a covariance matrix D whose elements are
known as variance components. Note that, unlike the random effects, the random errors are





represent all unknown parameters in the nonlinear mixed-effects
model (1). Unless a fully Bayesian approach is followed, the estimates of parameters are usually
obtained using the maximum likelihood estimation method. Denoting Yi = (Yi1, . . . , Yini)
′ and
assuming a multivariate normal distribution for the random effects bi, one can write the marginal
















where fi(yij |bi) denotes the conditional distribution of Yij given the random effects bi, and ϕ(bi)
is the density of the multivariate normal distribution with mean 0 and covariance matrix D.
As discussed in the introduction, Gauss-Hermite quadrature is a numerical approximation that
can provide an accurate approximation to the marginal log-likelihood (2) in order to facilitate
maximisation with respect to θ. Obviously, the random-effects distribution is crucial in the cal-
culation of the marginal log-likelihood function (2) and a misspecified random-effects distribution
could lead to biased parameter estimates.
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3. Gaussian quadrature for calculation of the marginal log-
likelihood
In this section we describe Gauss-Hermite quadrature for approximating the marginal log-likelihood
function (2). To avoid the numerical complexity with multiple integrals, one might change the
variables of integration in (2) to independent standard normally distributed random effects zi, as
suggested by Pinheiro and Bates 16 . This can be done by the Cholesky decomposition Q of the















. . . dziq, (3)
where φ(·) is the univariate standard normal density function. Now, Gaussian quadrature ap-













fi(yij |(ak, zi2, . . . , ziq)), (4)
where wk and ak are, respectively, the weights and abscissas (quadrature points) of the one-
dimensional Gauss-Hermite quadrature rule with K points. The K weights wk and the K ab-
scissas ak can be obtained from the tables of Abramowitz and Stegun
17 , or can be computed
as needed using an algorithm proposed by Golub 18 . Gauss-Hermite quadrature is available in
standard software packages like R and SAS. Note that the more quadrature points K are used,
the more accurate approximation is achieved. However, the use of a large number of quadrature
points can be computationally expensive. Often 10 quadrature points should be adequate to
obtain a reliable approximation19,20.
There are two versions of Gaussian quadrature: adaptive and non-adaptive. The main differ-
ence between them is that adaptive Gaussian quadrature centres the quadrature points around
the empirical Bayes estimates of random effects, while non-adaptive Gaussian quadrature cen-
tres the quadrature points around the expected value of random effects which is 0. Despite
the extra burden for calculation of the empirical Bayes estimates, adaptive Gaussian quadra-
ture generally provides more accurate results at lower numbers of quadrature points than its
non-adaptive counterpart. It is therefore more common to use adaptive Gaussian quadrature for
nonlinear mixed-effects models, though we consider both adaptive and non-adaptive techniques
when studying the impact of misspecification of the random-effects distribution.
5
4. The difficulty with theoretical assessment of bias due to
a misspecified random-effects distribution
This section aims to demonstrate that, for nonlinear mixed-effects models, it is difficult to obtain
theoretical results on bias of maximum likelihood estimates with a misspecified random-effects
distribution. Since we are interested in studying the consequences of misspecifying the random-
effects distribution, we assume that the conditional distribution fi(yi|bi) is correctly specified.
White 21 gives general theoretical results for misspecified maximum likelihood estimators, which
can be used in the context of mixed-effects models by investigating the case in which ϕ(bi) is
incorrectly assumed as the random-effects distribution. Let θ0 be the true parameter value,
which is unknown. Whatever the random-effects distribution is correctly specified or not, the
maximum likelihood estimator θ̂ML converges to θ∗ when N → ∞ (i.e., θ̂ML
P→ θ∗), where θ∗ is




















fi(yi|bi)g0(bi)dbi with g0(bi) as the true random-effects distribution.
Proposition 1. Under the general regularity conditions, if the assumed random-effects distribu-
tion is correctly specified (i.e., g0(bi) = ϕ(bi)), then θ∗ = θ0.
































Moreover, if g0(bi) = ϕ(bi) then f0i(yi) = fi(yi). Hence, we obtain, from (5) and (6), that
θ∗ = θ0.
Proposition 1 states that when the random-effects distribution is correctly specified, θ̂ML is
consistent for θ0. But, if the random-effects distribution is misspecified then θ∗ − θ0 is the exact
asymptotic bias of θ̂ML for estimating θ. Therefore, for a precise assessment of the bias of θ̂ML
in situations where the random-effects distribution is misspecified, one has to obtain θ∗ from (5).
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However, it is very difficult to obtain the exact value of θ∗ for nonlinear mixed-effects models
for two reasons. First, the true random-effects distribution g0(bi) is unknown, and second the
integral in (6) is analytically intractable for nonlinear mixed-effects models. It is even difficult to
find an approximate value of θ∗ from (5).
Considering the above theoretical challenge, since θ̂ML is consistent for θ∗ (as θ̂ML
P→ θ∗), we
can use θ̂ML − θ0 as an approximation to the actual bias θ∗ − θ0. It is more convenient to use
(θ̂ML−θ0)/θ0 as the approximate relative bias of the maximum likelihood estimator θ̂ML. In the
next section, we conduct simulations to evaluate the approximate relative bias of θ̂ML in both
small and large samples.
5. Simulation study
5.1. Overview
We conducted simulations to assess the impact of misspecifying the random-effects distribution
on estimation of parameters and prediction of random effects in nonlinear mixed-effects models.
Clearly, a simple model with one random effect is not very helpful in understanding the ac-








+ εij , (7)
which is in fact a one-compartment pharmacokinetic model, with
Ci = exp(β1 + bi1),
kai = exp(β2 + bi2),
kei = exp(β3 + bi3),
where the response Yij can be regarded as the drug concentration on subject i at time tij , Di is
the dose administered to subject i, kai is the fractional absorption rate constant for subject i, kei
is the fractional elimination rate constant for subject i, and Ci is the clearance for subject i
2.
For each sample size N = 20, 50, 100, 200, 500 and with 10 repeated measurements per subject,
we generated 500 data sets from the nonlinear mixed-effects model (7). In the simulations, we
set β1 = −3.2, β2 = 0.5, β3 = −2.4, and σ2 = 0.6. Also, for simplicity in the simulations,
we first assumed that the three random effects bi1, bi2, and bi3 are uncorrelated. The case of
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correlated random effects will be investigated later in this section. We generated each of the
three random effects bi1, bi2, and bi3 from four distinct distributions: N(0, 1), Chi-squared(2),
Log-normal(3, 1), and F(1, 7) where F denotes the Fisher distribution. All the generated random
effects were shifted and rescaled such that bi1, bi2, and bi3 have zero mean, but with variances
equal to d1 = 0.1, d2 = 0.3, and d3 = 0.1 respectively, in accordance with the real data example
in Section 6. The normality assumption on random effects is valid only when the random effects
are generated from N(0, 1), while the three other distributions used for generation of the random
effects represent the cases where the random-effects distribution is misspecified since the model
is fitted under the normality assumption of random effects.
5.2. The impact on estimation
First, using adaptive Gaussian quadrature we fitted the nonlinear mixed-effects model (7) to each
of the generated data sets under the normality assumption of bi1, bi2, and bi3. For each fitted
model, we calculated the maximum likelihood estimator θ̂ML for each of the model parameters
β1, β2, β3, σ
2, d1, d2, d3. Because we had 500 replications for each simulation setting which resulted





in which θ̂∗ML is the mean of maximum likelihood estimates obtained from the 500 replications.
Then, for each simulation setting, we computed the simulated relative bias of θ̂ML according to
(8). The simulations results are presented in Table 1. The results show that the estimates of
fixed-effects parameters and residual variance (reported as CV ) are quite robust to deviations
from normality of the random-effects distribution since the bias is very small, even for the small
sample sizes. This result is in line with the results for generalised linear mixed models10. But,
the estimates of variance components show a relatively large bias which does not tend to improve
with the sample size. This is in agreement with the results found for generalised linear mixed
models12. Also from the results in Table 1 we can see that, when the random-effects distribution
is correctly specified, the estimates of parameters tend to have smaller relative bias as the sample
size N increases, however the sample size does not help a model with misspecified random-effects
distribution. A justification for this could be that the random effects are latent and unobservable
variables and the data itself may not contain much information about their actual distribution.
Next, we used non-adaptive Gaussian quadrature to fit the nonlinear mixed-effects model
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Table 1: The simulated relative bias multiplied by 100 (and associated standard error multiplied by 100) of the
maximum likelihood estimates of parameters in the nonlinear mixed-effects model (7) using adaptive Gaussian
quadrature. The model was fitted under the normality assumption of random effects, whereas the random
effects were generated from four true random-effects distributions: N(0, 1), Chi-squared(2), Log-normal(3, 1),
and F(1, 7).
True distribution Parameter N = 20 N = 50 N = 100 N = 200 N = 500
β1 0.01 (8.1) −0.21 (4.8) −0.07 (3.6) −0.05 (2.5) 0.09 (1.6)
β2 2.36 (12.9) −1.68 (8.1) 0.20 (6.2) 0.83 (4.6) −0.46 (2.5)
β3 0.63 (9.2) −0.03 (5.2) 0.15 (4.4) 0.10 (2.7) 0.03 (1.9)
Normal(0, 1) CV −2.13 (7.2) 1.82 (4.2) −2.10 (3.0) −1.79 (2.3) −1.58 (1.4)
d1 −5.63 (3.6) −4.46 (2.3) −2.10 (1.9) −0.03 (1.4) −1.48 (0.7)
d2 −13.11 (11.3) −3.19 (8.3) 2.77 (5.7) 0.48 (3.9) 0.32 (1.7)
d3 −3.65 (4.6) 3.64 (4.0) 4.76 (3.1) 2.15 (2.5) 3.85 (1.6)
β1 0.85 (6.8) 1.37 (5.3) 1.55 (3.3) 1.63 (2.1) 1.62 (1.4)
β2 −4.88 (13.3) −2.34 (8.5) −1.51 (5.9) −1.46 (3.8) −2.30 (2.4)
β3 0.97 (8.7) 2.61 (6.2) 2.58 (4.6) 2.47 (2.7) 2.47 (1.8)
Chi-squared(2) CV 3.08 (7.2) 2.88 (4.8) 3.13 (3.5) 3.60 (2.3) 2.75 (2.2)
d1 −47.84 (4.0) −55.92 (3.0) −61.19 (1.9) −63.28 (1.1) −63.32 (7.8)
d2 −23.06 (16.2) −18.20 (11.9) −20.64 (5.8) −19.89 (4.9) −19.47 (2.6)
d3 31.50 (12.2) 61.59 (10.2) 81.77 (8.7) 88.98 (5.9) 86.75 (3.8)
β1 0.71 (7.3) 1.12 (4.4) 1.52 (2.9) 1.56 (2.2) 1.53 (1.3)
β2 −3.85 (10.8) −0.99 (7.8) −3.44 (5.6) −3.39 (3.2) −3.13 (2.7)
β3 1.40 (9.1) 1.83 (5.4) 2.32 (4.0) 2.24 (3.3) 2.38 (2.0)
Log-normal(3, 1) CV 3.43 (7.9) 3.05 (5.1) 3.96 (3.1) 3.72 (2.2) 3.09 (2.5)
d1 −56.21 (5.1) −67.68 (2.6) −73.22 (1.3) −74.28 (1.0) −74.14 (0.6)
d2 −37.94 (18.3) −38.05 (7.4) −42.02 (5.8) −42.49 (3.6) −41.45 (2.7)
d3 18.93 (11.6) 43.09 (9.5) 57.36 (8.2) 74.39 (5.5) 61.72 (4.9)
β1 0.94 (6.2) 1.20 (3.6) 1.40 (3.1) 1.48 (2.0) 1.55 (1.1)
β2 −4.52 (9.4) −2.39 (6.8) −3.34 (4.7) −2.55 (3.3) −2.22 (2.0)
β3 1.84 (9.0) 1.77 (6.2) 2.14 (3.9) 2.23 (3.1) 2.43 (1.8)
F(1, 7) CV 4.18 (7.9) 3.51 (4.6) 3.86 (3.5) 3.80 (2.4) 3.77 (2.6)
d1 −69.75 (4.1) −80.45 (1.7) −80.75 (1.4) −82.24 (1.0) −84.18 (0.4)
d2 −54.96 (11.4) −46.03 (9.0) −48.92 (5.7) −48.70 (4.1) −48.64 (2.3)
d3 19.14 (15.0) 49.95 (11.7) 59.56 (9.8) 46.79 (5.3) 60.29 (3.5)
(7) to the generated data sets. For this case, we repeated the above calculations to obtain the
simulated relative bias of θ̂ML using (8). The simulations results, which are reported in Table
2, are very similar to those from the adaptive Gaussian quadrature, and the only difference
is that the estimates of variance components show little bias under the correct random-effects
distribution. This is probably due to the fact that non-adaptive Gaussian quadrature centres
the quadrature points around the expected value of 0 instead of the empirical Bayes estimates of
random effects.
To understand the role of correlated random effects and the number of repeated measurements
on parameter estimation under a misspecified random-effects distribution, we conducted a similar
simulation study for the nonlinear mixed-effects model (7), where we used the number of repeated
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Table 2: The simulated relative bias multiplied by 100 (and associated standard error multiplied by 100) of
the maximum likelihood estimates of parameters in the nonlinear mixed-effects model (7) using non-adaptive
Gaussian quadrature. The model was fitted under the normality assumption of random effects, whereas the
random effects were generated from four true random-effects distributions: N(0, 1), Chi-squared(2), Log-
normal(3, 1), and F(1, 7).
True distribution Parameter N = 20 N = 50 N = 100 N = 200 N = 500
β1 −0.16 (8.2) 0.23 (6.7) 0.08 (5.4) 0.01 (3.7) 0.17 (2.9)
β2 −2.23 (11.7) 0.18 (11.9) 1.85 (7.3) 0.05 (5.5) 0.13 (4.1)
β3 0.23 (8.3) −1.12 (8.2) −1.02 (6.7) −0.55 (3.8) −0.70 (3.0)
Normal(0, 1) CV −5.20 (6.4) 7.11 (4.6) 11.99 (6.1) 5.02 (2.9) 6.45 (3.6)
d1 −0.65 (3.3) −6.06 (2.8) 0.67 (3.3) 0.73 (1.6) 1.07 (1.5)
d2 8.46 (11.3) −6.24 (8.0) −21.05 (4.6) −10.42 (4.1) −11.72 (3.2)
d3 −7.53 (4.1) −31.16 (2.4) −28.21 (2.5) −19.84 (1.7) −21.43 (1.1)
β1 1.13 (8.1) 1.29 (4.9) 1.37 (4.8) 1.65 (3.2) 1.74 (2.8)
β2 1.32 (12.7) −3.28 (9.0) −6.80 (7.5) −3.95 (6.5) −1.28 (4.7)
β3 1.36 (7.9) 0.08 (8.5) 0.77 (6.1) 0.52 (5.7) 0.20 (9.3)
Chi-squared(2) CV −5.21 (6.6) 7.33 (4.5) 10.72 (5.9) 12.14 (6.3) 13.76 (7.4)
d1 −14.81 (5.8) −21.73 (5.3) −31.48 (5.5) −48.14 (3.6) −47.59 (4.1)
d2 −14.70 (10.9) −21.82 (9.6) −25.92 (7.9) −33.78 (5.0) −38.87 (3.7)
d3 −16.13 (4.8) 0.05 (4.9) 8.45 (3.7) 17.23 (5.1) 38.97 (7.6)
β1 −1.59 (5.2) 0.86 (6.5) 1.13 (4.8) 0.97 (4.3) 1.93 (2.9)
β2 4.12 (13.0) −7.46 (8.2) −7.99 (8.9) −7.97 (7.2) 4.10 (7.5)
β3 0.69 (6.9) −0.38 (8.6) −0.05 (11.3) −1.42 (13.2) −2.52 (10.7)
Log-normal(3, 1) CV −4.95 (6.3) 7.21 (6.1) 9.66 (5.9) 10.79 (6.8) 13.81 (7.2)
d1 −37.90 (5.4) −32.74 (6.7) −61.97 (2.9) −68.05 (2.7) −62.75 (0.7)
d2 −15.94 (2.0) −42.36 (8.1) −45.29 (7.0) −46.41 (6.5) −45.61 (4.4)
d3 −24.14 (5.2) 6.72 (8.8) 31.17 (9.7) 72.53 (6.6) 57.66 (11.4)
β1 0.69 (7.5) 1.13 (5.4) 0.86 (4.0) 0.80 (3.8) 1.06 (2.6)
β2 −6.68 (12.3) −3.32 (8.1) −0.24 (7.7) −12.71 (5.9) −4.65 (5.8)
β3 0.36 (10.8) 0.42 (8.7) −0.90 (11.9) −1.22 (9.8) −5.09 (13.8)
F(1, 7) CV −4.09 (5.9) 6.70 (4.7) 9.51 (5.4) 9.94 (6.5) 12.87 (7.1)
d1 −36.07 (9.3) −56.04 (3.8) −60.66 (3.9) −83.04 (10.8) −85.21 (0.6)
d2 −50.74 (10.5) −50.96 (7.1) −44.26 (7.2) −59.14 (3.2) −50.49 (5.9)
d3 −0.15 (8.0) −0.98 (8.2) 53.19 (10.2) 17.45 (5.9) 63.37 (16.8)
measurements ni = 5, 10, 20 and fixed N = 30. Here the random effects were generated from
two multivariate distributions: a multivariate normal distribution and a multivariate log-normal
distribution. The simulation results, presented in Table 3, suggest that increasing the number
of repeated measurements would help the estimates of the fixed-effects parameters, however it
does not improve the estimates of variance components when the random-effects distribution
is misspecified. Furthermore, similar to the previous results in Table 1 and Table 2, when the
random effects are correlated the estimates of variance components show high relative bias under
a misspecified random-effects distribution.
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Table 3: The simulated relative bias multiplied by 100 (and associated standard error multiplied by 100) of
the maximum likelihood estimates of parameters in the nonlinear mixed-effects model (7) with N = 30 and
with the number of repeated measurements ni = 5, 10, 20, using adaptive Gaussian quadrature for the two
multivariate random-effects distributions considered.
True distribution Parameter ni = 5 ni = 10 ni = 20
β1 −0.69 (7.9) −0.11 (6.2) −0.06 (3.2)
β2 −6.60 (10.1) −3.01 (8.7) 0.52 (4.1)
β3 −1.19 (8.2) 0.17 (5.9) −0.17 (3.3)
CV −2.48 (7.6) 2.91 (5.4) 2.95 (3.5)
Multivariate normal d11 −7.31 (6.1) −5.56 (4.6) −3.60 (2.8)
d12 8.08 (5.9) −4.25 (4.3) −2.46 (3.0)
d22 10.10 (6.2) −5.12 (4.8) −3.91 (3.1)
d13 −8.19 (5.3) −5.15 (4.6) 2.52 (2.9)
d23 −9.28 (4.9) −6.24 (3.9) 1.03 (3.1)
d33 −6.23 (5.9) −4.40 (4.3) −2.10 (2.9)
β1 −1.22 (8.3) −1.20 (6.2) 0.73 (4.0)
β2 −12.57 (9.8) −2.36 (8.5) −1.14 (3.7)
β3 −5.09 (10.2) 1.38 (6.3) −1.15 (3.4)
CV 4.16 (8.1) 3.02 (6.2) 2.80 (3.6)
Multivariate log-normal d11 −49.11 (7.9) −46.23 (5.5) −42.11 (4.2)
d12 −21.24 (8.0) −18.16 (5.3) −16.31 (3.7)
d22 −36.77 (7.7) −35.13 (5.3) −34.85 (4.0)
d13 −20.06 (6.1) −16.35 (5.0) −17.11 (3.5)
d23 23.01 (5.8) 24.19 (4.8) 19.85 (2.9)
d33 −31.16 (7.3) −29.98 (5.0) −28.79 (3.3)
5.3. The impact on prediction
We then investigated how misspecification of the random-effects distribution affects the prediction
of random effects in the nonlinear mixed-effects model (7). Our approach to assessing the impact
on predictions is based on the comparison of the predicted values of random effects obtained under
the true distribution with those obtained under a misspecified random-effects distribution. This
approach makes sense because the true model is believed to produce correct predictions, especially
when the sample size is large enough (N ≥ 200), and our simulation results in Table 1 and Table
2 confirm that the model fitting is generally accurate under the true random-effects distribution.
Recall that in our simulations N(0, 1) represents the case where the random-effects distribution
is correctly specified, while Chi-squared(2), Log-normal(3, 1), and F(1, 7) are used for the cases
where the random-effects distribution is misspecified as the model is fitted under the normality
assumption of random effects. Figure 1 shows the predictions of random effects for two sample
sizes of 200 and 500 obtained for these four distributions using adaptive Gaussian quadrature. It
can be seen that the misspecified random-effects distributions tend to overestimate the predictions
(see Figure 1(c,d,e,f)) or underestimate the predictions (see Figure 1(a,b)). In fact, the predictions
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of random effects are influenced with the shape of the random-effects distribution. A similar
behaviour is observed for the predictions obtained using non-adaptive Gaussian quadrature (see
Figure 2).
6. A diagnostic test for checking the random-effects distri-
bution
In the previous sections we studied the impact of misspecifying the random-effects distribution
on estimation and prediction. We now describe a formal diagnostic test to verify whether an
assumed random-effects distribution is correctly specified or not.
Let G be the assumed random-effects distribution, which is typically a multivariate normal
distribution (i.e., G = ϕ). To check the appropriateness of the assumed random-effects distri-
bution G, Verbeke and Molenberghs 22 suggested to use the so-called gradient function given
by







, b ∈ Rq, (9)
where fi(yi|b) and fi(yi|G) are, respectively, the conditional (given random-effect point b) and
marginal distributions of Yi. They proved that if the random-effects distribution G is correctly
specified, then ∆ (G, b) ≤ 1 for all b ∈ Rq, and furthermore ∆ (G, b) = 1 for all b in the support
of G. Therefore, deviations of the gradient function from 1 in the support points of G indicate
inadequacy of G. As an informal approach, they suggested to plot the gradient function versus
points b in the support of G, and if the gradient plot is close to 1 then the adequacy of G is
confirmed. Note that the gradient can be interpreted as an average of likelihood ratios, each
ratio measuring how much more likely Yi is to be observed for subject i if the corresponding
random effect bi equals b rather than being sampled from the distribution G. It can be seen that
the calculation of the gradient function is easy because it only requires the calculation of the
marginal and conditional distributions for all N subjects.
Based on the gradient function (9), we recently developed a formal diagnostic test for the
random-effects distribution (see Drikvandi et al. 4). Suppose that the null hypothesis H0 says
the random-effects distribution G is correctly specified and the alternative hypothesis H1 says
otherwise. Having considered all deviations of the gradient function from 1, we constructed a
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(a) Prediction of bi1 when N = 200. (b) Prediction of bi1 when N = 500.
(c) Prediction of bi2 when N = 200. (d) Prediction of bi2 when N = 500.
(e) Prediction of bi3 when N = 200. (f) Prediction of bi3 when N = 500.
Figure 1: The prediction of random effects in the nonlinear mixed-effects model (7) using adaptive Gaussian
quadrature. The model was fitted under the normality assumption of random effects, whereas the random
effects were generated from the four true random-effects distributions considered.
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(a) Prediction of bi1 when N = 200. (b) Prediction of bi1 when N = 500.
(c) Prediction of bi2 when N = 200. (d) Prediction of bi2 when N = 500.
(e) Prediction of bi3 when N = 200. (f) Prediction of bi3 when N = 500.
Figure 2: The prediction of random effects in the nonlinear mixed-effects model (7) using non-adaptive
Gaussian quadrature. The model was fitted under the normality assumption of random effects, whereas the
random effects were generated from the four true random-effects distributions considered.
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where Ĝ is the estimated random-effects distribution obtained by replacing the covariance matrix
D by its maximum likelihood estimate, and ∆̂ denotes the estimated gradient function based on Ĝ
obtained simply by replacing the unknown parameters in fi (yi|b) and fi(yi|Ĝ) by their maximum
likelihood estimates. If T deviates much from 0, we can reject H0 implying that the assumed
random-effects distribution G is not appropriate for random effects.
The asymptotic distribution of T is given in Theorem 1 of Drikvandi et al. 4 , which is essen-
tially a weighted sum of independent chi-squared distributions each with one degree of freedom.
However, the asymptotic distribution should only be used when the sample size N is sufficiently
large. For small-sample situations, we also proposed a parametric bootstrap procedure to obtain
the finite-sample distribution of the test statistic T in (10). The key step in our bootstrap proce-
dure, in order to obtain a bootstrap sample, is to first generate random effects bsi , i = 1, . . . , N ,
from Ĝ and then generate a bootstrap sample Y si , i = 1, . . . , N , from f̂i(yi|bsi ). We use 200
bootstrap samples to conduct the bootstrap test. Below we illustrate how the bootstrap test
based on (10) can be performed.
Implementation of the bootstrap test
The bootstrap test can be carried out by the following steps:
1. Generate K, say 1000, random-effect points bk from Ĝ.
2. Compute the gradient function (9) and its squared deviation from 1 for each bk.
3. Calculate the test statistic T being the average of the K squared deviations obtained in
step 2 (which is the Monte Carlo approximation of T ), and denote it by Tobs.
4. For each bootstrap step s, s = 1, . . . , 200, repeat the following two steps:
i. First generate random effects bsi , i = 1, . . . , N , from Ĝ and then generate a bootstrap
sample Y si , i = 1, . . . , N , from f̂i(yi|bsi ).
ii. Calculate the test statistic T for the bootstrap sample obtained in step i and denote it
by T s.
5. If the proportion of T s exceeding Tobs is less than 0.05, then reject H0, indicating that the




Figure 3: Type I error and power of the bootstrap test at the significance level 0.05 for detecting the mis-
specification of random-effects distribution in the nonlinear mixed-effects model (7) using adaptive Gaussian
quadrature, with the four true random-effects distributions considered: (a) Normal(0, 1), (b) Chi-squared(2),
(c) Log-normal(3, 1), and (d) F(1, 7). Note that the Type I error is for the case of Normal(0, 1) where the
random-effects distribution is correctly specified.
We evaluated the empirical performance of this bootstrap test for a general class of mixed-
effects models in Drikvandi et al. 4 . Here we calculated the power and Type I error of the
permutation test at the 5% significance level for the nonlinear mixed-effects model (7), under the
same simulation setting as in Section 5 and with the additional sample size of N = 1000. The
results, presented in Figure 3, indicate that the bootstrap test has a Type I error close to the
nominal level 0.05 and further it shows a high power for detecting the misspecification of random-
effects distribution, especially when the sample size N is sufficiently large (e.g., N ≥ 100). We
prepared a SAS code for implementation of the above test which is available online on the journal
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Figure 4: Theophylline data: individual profiles for 12 subjects.
7. Real data application
Theophylline is a well-known anti-asthmatic agent, administered orally23,24. In a pharmacoki-
netic study, 12 subjects were given the same oral dose (mg/kg) of theophylline, and blood samples
were taken at several times following administration were assayed for theophylline concentra-
tion24. The main objective was to gain insight into within-subject pharmacokinetic processes of
absorption, distribution, and elimination governing concentrations of drug achieved. The individ-
ual profiles, presented in Figure 4, show that the theophylline concentrations have a similar shape
for all subjects, but peak concentration achieved, rise, and decay vary significantly across the sub-
jects. These differences are due to the inter-subject variability in the underlying pharmacokinetic
processes, understanding of which is critical for developing dosing guidelines.
To characterise these processes formally, we consider the one-compartment model (7) with
first-order absorption and elimination, as also suggested by Davidian and Giltinan 24 . The inter-
subject variability in the pharmacokinetic processes is accounted for by the subject-specific ran-







. We fit the one-compartment model (7) to the theophylline data, by as-
suming two different multivariate distributions for the random effects (bi1, bi2, bi3): a multivariate
normal distribution and a multivariate log-normal distribution. The maximum likelihood esti-
mates of parameters along with their associated standard errors obtained under each distribution
are reported in Table 4. It can be seen that the estimates of fixed-effects parameters are similar
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Table 4: Theophylline data: the maximum likelihood estimates of parameters and associated standard errors
obtained from fitting the one-compartment model (7), once assuming a multivariate normal distribution for
the random effects, once assuming a multivariate log-normal distribution for the random effects. Note that
the test statistics and p-values are reported only for the multivariate normal distribution.
Multivariate normal Multivariate log-normal
Parameter Estimate (s.e.) t-value p-value Estimate (s.e.)
Fixed effects:
β1 −3.277 (0.046) −70.64 < 0.0001 −3.053 (0.188)
β2 0.537 (0.063) 8.52 < 0.0001 0.701 (0.380)
β3 −2.454 (0.064) −38.38 < 0.0001 −2.395 (0.079)
Residual variance:
σ2 0.624 (0.083) 7.55 < 0.0001 0.542 (0.080)
Variance components:
d11 0.057 (0.022) 2.56 0.0308 0.631 (0.461)
d12 −0.012 (0.018) −0.67 .5188 −0.018 (0.027)
d22 0.264 (0.054) 4.92 0.0008 2.215 (1.852)
d13 0.030 (0.020) 1.52 0.1636 0.039 (0.025)
d23 −0.025 (0.017) −1.47 0.1743 −0.043 (0.034)
d33 0.035 (0.017) 2.05 0.0702 0.090 (0.056)
−2 log-likelihood 341.7 358.6
under the two assumed random-effects distributions, but the estimates of variance components
are quite different. These results are consistent with our simulation findings in Section 5. Note
that the test statistics and p-values are reported only for the multivariate normal distribution,
and one should be cautious about the p-values for variance components because their associated
tests require testing on the boundary of the parameter space25.
Since the true random-effects distribution is unknown, it is not clear which parameter es-
timates in Table 4 are correct, though the multivariate normal distribution provides a larger
marginal likelihood. To check this formally, we apply the diagnostic bootstrap test in Section
6 to see whether a multivariate normal distribution is appropriate for the random effects. The
bootstrap test with 200 bootstrap samples and with 1000 Monte Carlo integration nodes pro-
duces a test statistic of 3.91, giving a p-value of 0.15. This suggests that a multivariate normal
distribution is appropriate for the random effects bi1, bi2 and bi3.
Pharmacokineticists are more interested in the estimates of pharmacokinetic parameters Ci,
kai, and kai. Figure 5 shows that the estimates of pharmacokinetic parameters for the theophylline
data are roughly similar between the two different random-effects distributions. It is because the
estimates of pharmacokinetic parameters here are more affected by the estimates of fixed-effects




Figure 5: Theophylline data: the estimates of pharmacokinetic parameters for the 12 subjects. In
each plot, the filled dot symbol is used to show the estimates obtained under the multivariate normal
distribution for random effects, while the triangle symbol is used to show the estimates obtained the
multivariate log-normal distribution for random effects.
8. Conclusions and discussion
Since random effects are latent and unobservable variables, it is difficult to find out their true
underlying distribution. Consequently, in practice, the random-effects distribution can be subject
to misspecification. We presented a formal diagnostic test to check the appropriateness of the
assumed random-effects distribution in nonlinear mixed-effects models. Such a diagnostic tool is
very useful for practical use.
In the paper, we focused on Gauss-Hermite quadrature which is now the default method in
standard software (nlmer function in R and PROC NLMIXED in SAS), and generally provides
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reliable approximation to the marginal likelihood in nonlinear mixed-effects models. This enabled
us to obtain fair results on consequences of misspecifying the random-effects distribution. The
theory suggests that the maximum likelihood estimates of parameters in nonlinear mixed-effects
models with a misspecified random-effects distribution are not asymptotically unbiased. The
asymptotic bias is equal to θ∗− θ0 where θ∗ is the minimiser of the Kullback-Leibler information
criterion and θ0 is the true parameter value. Because calculation of θ∗ is difficult, we used the
maximum likelihood estimator θ̂ML as a consistent estimator of θ∗ for evaluating the bias in our
simulations.
The main findings/conclusions of our simulation studies and real data analysis are summarised
below. We should emphasise that these results essentially apply to the model and range of
scenarios considered in the simulations and real data application.
• The maximum likelihood estimates of fixed-effects parameters are robust to the normality
assumption of random effects.
• The maximum likelihood estimate of residual variance is also robust to the normality as-
sumption of random effects.
• The maximum likelihood estimates of variance components show substantial bias when the
random-effects distribution is misspecified.
• Predictions of random effects are highly affected with a misspecified random-effects distri-
bution and, in fact, they are either overestimated or underestimated.
• The sample size N and the number of repeated measurements ni do not help much with
the relative bias of the maximum likelihood estimates of variance components when the
random-effects distribution is misspecified. A possible reason is that the random-effects
distribution is a mixing distribution, and mainly the marginal distribution will benefit from
increasing the sample size.
• All the above conclusions hold for both adaptive and non-adaptive Gaussian quadrature.
The only difference between the results from these two methods was that the estimates
of variance components obtained using non-adaptive Gaussian quadrature show little bias
under the correct random-effects distribution. This is due to the fact that non-adaptive
Gaussian quadrature centres the quadrature points around the expected value of 0 instead
of the empirical Bayes estimates of random effects.
In our simulations, the variances of the random effects (d1 = 0.1, d2 = 0.3, and d3 = 0.1) were
very small and we chose them based on the case study. In another simulation study (not reported
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in the paper) with the same settings but with larger variance components, we found similar
results for the fixed-effects parameters, but the impact of the mispecification on the estimates of
variance components and predictions of random effects was more substantial when the variance
components are larger, that is, the relative bias of the estimates of variance components tends to
be higher and the predictions of random effects tend to get farther from the true predictions.
The fact that the estimates of fixed-effects parameters (often the main parameters of inter-
est) are robust to departures from normality of the random-effects distribution should not be a
reason to depreciate the distributional assumptions on random effects because, as our simula-
tions revealed, the estimates of variance components and predictions of random effects are highly
affected with such misspecification. Clearly, variance components are crucial in calculation of
the standard errors of the fixed-effects parameters estimates, hence wrong estimates of them
could affect the confidence intervals and hypothesis tests regarding the fixed-effects parameters
(see26,27). Moreover, individual-specific inferences could be misleading when the predictions of
random effects are inaccurate.
Last but not least, the more random effects, the more challenging their distribution would be.
Therefore, it is important to avoid any unnecessary random effects in the model. This can be
done, for example, via a test for zero random effects. Classical tests such as the likelihood ratio
and score tests cannot be easily applied to this testing problem because it requires testing on the
boundary of parameter space. Bootstrap and permutation tests have been suggested for testing
random effects in linear and generalised linear mixed models25,28,29, however little is known on
testing random effects in nonlinear mixed-effects models. Developing such tests for random effects
in nonlinear mixed-effects models will be very helpful.
9. Data availability statement
The data that support the findings of this paper are available from the author upon request.
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